USDA is committed to helping farmers produce healthy,
affordable food in a sustainable manner that protects this country’s natural
resources and offers more choices for consumers. Through innovative methods,
plant scientists can now create new plant varieties that are indistinguishable
from those developed through traditional breeding methods. These new approaches
to plant breeding include methods like genome editing and present tremendous
opportunities for farmers and consumers alike by making available plants with
traits that may protect crops against threats like drought and diseases,
increase nutritional value, and eliminate allergens.
In keeping with our responsibility to protect plant health,
USDA has carefully reviewed products of these new technologies to determine
whether they require regulatory oversight.
As USDA works to modernize its biotechnology regulations, the
vision and direction of this Department will be to continue to focus regulatory
initiatives on the basis of risk to plant health.
Under its biotechnology regulations, USDA does not currently
regulate, or have any plans to regulate plants that could otherwise have been
developed through traditional breeding techniques as long as they are developed
without the use of a plant pest as the donor or vector and they are not
themselves plant pests. This can include plant varieties with the following
changes:
- Deletions—the change to the plant is solely a
genetic deletion of any size.
- Single base pair substitutions—the change to
the plant is a single base pair substitution.
- Insertions from compatible plant relatives—the
change to the plant solely introduces nucleic acid sequences from a
compatible relative that could otherwise cross with the recipient organism
and produce viable progeny through traditional breeding.
- Complete Null Segregants—off-spring of a genetically engineered plant that does not retain the change of its parent.
The Press Release also notes that other agencies also
regulate biotechnology innovations, such as the Food and Drug Administration
and the Environmental Protection Agency. For more on access to the CRISPR technology, see this IP Finance post.
No comments:
Post a Comment